Approval Of GW Pharma's Cannabidiol Epidiolex 'No Longer A Pipe Dream'

Set to be the first FDA-approved cannabidiol-based drug, Epidiolex would treat seizures associated with the rare childhood epilepsy indications Lennox-Gastaut syndrome and Dravet syndrome.